Home › NDC Lookup › Ingredients › Glycerin › 00132-0185-82
Fleet glycerin 5.4 g Liquid, 4-count — NDC 00132-0185-82 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Fleet glycerin 5.4 g Liquid, 4-count — NDC 0132-0185-82 (Billing 00132-0185-82)

by C.B. Fleet Company, Inc. · 4 LIQUID in 1 CARTON

This is a package of 4 liquids of Fleet glycerin 5.4 g Liquid from C.B. Fleet Company, Inc., marketed since Jun 2002 and currently FDA-listed; retail pharmacies pay about $0.1386 per mL (NADAC). It is the main listing for this product, which comes in 2 package sizes.

NDC 00132-0185-82
🏷️ FDA NDC (as labeled) 0132-0185-82 billing pads the labeler segment with a zero
This package
Contains4-count Cost per mL$0.1386 NADAC Pack sizes2 compare ↓
Also priced by: Medicaid pays $0.0986/unit — full pricing hub ↓
Main listing for product 0132-0185 · Also comes in: 1 liquid 0132-0185-01
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Other active recalls for Glycerin (different manufacturers) — 4 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Apr 27, 2026 — Lack of Assurance of Sterility: The recall is being initiated out of an abundance of caution following FDA observations noted during a recent inspection of Excelvision. (Oasis Medical, Inc.) · FDA recall D-0525-2026
Class II · Apr 20, 2026 — Lack of Assurance of Sterility (SCOPE HEALTH) · FDA recall D-0499-2026
Class II · Mar 25, 2026 — Lack of Assurance of Sterility (Preferred Pharmaceuticals, Inc.) · FDA recall D-0443-2026
Class II · Mar 3, 2026 — Lack of Assurance of Sterility (K.C. Pharmaceuticals, Inc) · FDA recall D-0411-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0132-0185-82
Product NDC 0132-0185
11-digit billing NDC 00132018582
NCPDP billing unit ML — per mL (volume)
RxCUI 596936
UNII PDC6A3C0OX
Application # M007
SPL Set ID 381f4179-0c3b-41f8-927c-c88534ebe06d
Established class (EPC) Non-Standardized Chemical Allergen
Physiologic effect Increased Histamine Release; Cell-mediated Immunity; Increased IgG Production
Chemical class Allergens; Glycerol
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2002-06-03
Route RECTAL
Dosage form LIQUID
Substance GLYCERIN

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 46600010005120
GPI class Fleet Liquid Glycerin Supp
GCN Seq No 068671
GCN 31496
HICL code 001312
Ingredient (HICL) Glycerin
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q3
Therapeutic class — intermediate (HIC2) Anal-Rectal Preparations
HIC3 code Q3S
Therapeutic class — specific (HIC3) Laxatives, Local/Rectal
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name FLEET GLYCERIN LIQUID SUPP
FDB brand name Glycerin Laxative
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 068671
  • GCN: 31496
  • GPI-14 (Medi-Span): 46600010005120
  • HICL (First Databank): 001312
  • AHFS class code: 56:12.00.00
  • RxCUI (RxNorm): 596936
Why two NDCs? The FDA registers this code as 0132-0185-82 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00132-0185-82. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Non-Standardized Chemical Allergen class.

Pharmacologic class Non-Standardized Chemical Allergen
Drug family (ATC) Enemas, Other drugs for constipation
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name FLEET GLYCERIN LIQUID SUPP Ingredient Glycerin
🧪 What is this product?

Fleet glycerin is a rectal liquid product sold over the counter under FDA's OTC monograph rules. It contains glycerin as its active ingredient, which is typically used as an osmotic agent to draw fluid into the colon and help relieve occasional constipation. This type of product functions as a rectal laxative and is applied directly into the rectum.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.139 —
Medicaid paysCMS SDUD · 12 mo $0.0986 —
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Nov 2021 Dec 2025 Mar 2026 Jul 2026 $0.139 $0.114
▲ Up 22% over the last 7 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
00132-0185-01 0132-0185-01 1 LIQUID in 1 PACKAGE — — 2002-06-03 — Discontinued by firm
00132-0185-82 You're viewing this Main listing 4 LIQUID in 1 CARTON $0.1386 / mL — 2002-06-03 — Active

You're viewing the largest of 2 pack sizes for this product.

In Medicaid, this is the most-dispensed pack of this product — about 100% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This is a 4-count package — 4 liquid in 1 carton.
How does this package differ from NDC 00132-0185-01?
Both are Fleet glycerin 5.4 g Liquid — the drug itself is identical. This page's package is the 4-count one, while NDC 00132-0185-01 is the 1 liquid package.
What NDC number is used to bill for this package of Fleet glycerin 5.4 g Liquid?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Fleet 5.4 gthis 00132-0185-82 C.B. 4 liquids $0.139 — Availability likely —
Walgreens Glycerin 5.4 g 00363-0499-06 Walgreens 6 bottles — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2002
On the market since
Jun 2002
📍
2026
Currently FDA-listed
24 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 7FLD91C86K
    Edetate disodium is a chemical compound that binds and removes certain metal ions. In medicines, it acts as a preservative and stabilizer by preventing metals like calcium from interfering with the product's shelf life and consistency.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

2 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesedetate disodium, purified water

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerC.B. Fleet Company, Inc.
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code00132
First marketedJun 2002
Product typeHuman Otc Drug
Portfolio23 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 19 words ▾

Use for relief of occasional constipation. This product usually produces a bowel movement in 15 minutes to 1 hour.

⏱️ Dosage and Administration ~1 min read ▾

Directions Single D aily D osage (per 24 hours ) A dults and children 6 years and over 1 suppository or as directed by a doctor C hildren 2 to under 6 years use Fleet ® Pedia-Lax ® Liquid C hildren under 2 years consult a doctor Left-side position: Lie on left side with right knee bent and arms resting comfortably. Knee-chest position: Kneel, then lower head and chest forward until left side of face is resting on surface with left arm folded comfortably Administering the laxative: CAUTION: REMOVE ORANGE PROTECTIVE SHIELD BEFORE INSERTING.

Hold unit upright, grasping bulb of unit with fingers. Grasp orange protective shield with other hand, pull gently to remove. With steady pressure, insert tip into rectum with a slight side-to-side movement, with tip pointing toward navel.

Do not force the applicator tip into the rectum, as this can cause injury. Insertion may be easier if person receiving suppository bears down as if having a bowel movement. This helps relax the muscles around the anus.

Squeeze the bulb until nearly all liquid is expelled. While continuing to squeeze the bulb, remove tip from rectum and discard unit. It is not necessary to empty unit completely.

The unit contains more than the amount of liquid needed for effective use. A small amount of liquid will remain in the unit after use. For a more detailed step-by-step instructional video on how to use Fleet ® products, visit our website www.fleetlabs.com to watch the “how to use” video.

⚠️ Warnings 109 words ▾

Warnings May cause rectal discomfort or a burning sensation. For rectal use only. Do not use when abdominal pain, nausea, or vomiting are present unless directed by a doctor.

Ask a doctor before using any laxative if you have a sudden change in bowel habits lasting more than 2 weeks already used a laxative for more than 1 week Stop using this product and consult a doctor if you have rectal bleeding no bowel movement within 1 hour of using this product These symptoms may indicate a serious condition. Keep out of reach of children . If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 12 words ▾

Active Ingredient (in each 5.4 mL average delivered dose) Glycerin 5.4 g

🧪 Inactive Ingredients 6 words ▾

Inactive Ingredients edetate disodium, purified water

🎯 Purpose 3 words ▾

Purpose Hyperosmotic Laxative

📄 Do Not Use 16 words ▾

Do not use when abdominal pain, nausea, or vomiting are present unless directed by a doctor.

📄 Ask a Doctor Before Use If 30 words ▾

Ask a doctor before using any laxative if you have a sudden change in bowel habits lasting more than 2 weeks already used a laxative for more than 1 week

📄 Stop Use and Ask a Doctor If 30 words ▾

Stop using this product and consult a doctor if you have rectal bleeding no bowel movement within 1 hour of using this product These symptoms may indicate a serious condition.

📄 Keep Out of Reach of Children 20 words ▾

Keep out of reach of children . If swallowed, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 4 words ▾

Questions? 1-866-255-6960 or www.fleetlabs.com

📄 Package Label / Principal Display Panel 26 words ▾

PRINCIPAL DISPLAY PANEL Fleet Laxative Liquid Glycerin Suppositories 4Adult Suppositories 7.5 ml each PRINCIPAL DISPLAY PANEL Fleet Laxative Liquid Glycerin Suppositories 4Adult Suppositories 7.5 ml each

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
542
Units reimbursed last 4 qtrs
321.6K
Gross reimbursed last 4 qtrs
$31.7K
Avg / prescription
$58.47
Avg / unit
$0.0986
Latest quarter Q1 2026
111Rx
Medicaid pays / mL
$0.0986
gross reimbursed
vs
NADAC / mL
$0.1386
acquisition cost
=
Spread
−$0.0400
-29% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
70% FFS 30% MCO
Fee-for-service · 379 Rx Managed care · 163 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: 33,690 units · 570 per 100k residents WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: 37,155 units · 315 per 100k residents OH Pennsylvania: 29,109 units · 225 per 100k residents PA New Jersey: no data reported NJ Massachusetts: 143,243 units · 2,046 per 100k residents MA California: 65,918 units · 169 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: 3,450 units · 76.2 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: 9,000 units · 121 per 100k residents AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
76.22,046
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Massachusetts 2,046 /100k
2 Wisconsin 570 /100k
3 Ohio 315 /100k
4 Pennsylvania 225 /100k
5 California 169 /100k
6 Arizona 121 /100k
7 Kentucky 76.2 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
1 liquid00132-0185-01 No Medicaid data
Drug total (last 4 qtrs): 542 Rx · 321,564 units · $31,691 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.